Copy number variations and cancer susceptibility
The DOI matches its Crossref record; 75 of the 77 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: DNA copy number variations (CNVs) comprise a recently discovered element of genetic variation that affects a greater cumulative fraction of the genome than single-nucleotide polymorphisms (SNPs). This review discusses current understanding of the characteristics of CNVs in the human genome and explores the emerging discoveries of both constitutional and somatic CNVs in an ever-expanding variety of human cancers. RECENT FINDINGS: The advent of high-resolution SNP arrays has made it possible to identify CNVs. Characterization of widespread constitutional CNVs offers insight into their role in disease susceptibility, whereas somatic CNVs identify regions of the genome involved in disease phenotype. The role of CNVs in cancer has only emerged in the last 2 years, with constitutional CNVs originally being observed in the Li-Fraumeni cancer susceptibility syndrome, and more recently in neuroblastoma. SUMMARY: It is not yet known how common or how functionally relevant CNVs will be to the process of carcinogenesis. Nonetheless, the inherent instability and structural variability that characterize cancer cell genomes make this form of genetic variation particularly intriguing to the study of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CNVs are involved in a large number of complex human diseases such as Down’s syndrome (trisomy 21) and many cancers, for example HER2 gene amplification in breast cancer (BC) (1–5).”
From Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation (2012) · cites this paper as [1]
Citations
Cites
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Global variation in copy number in the human genome
Redon, R., Ishikawa, S., Fitch, K. R., Feuk, L., Perry, G. H., Andrews, T. D., Fiegler, H., Shapero, M. H., Carson, A. R., Chen, W., et al. (2006) · Nature · doi:10.1038/nature05329 · Cited by 4,288
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Detection of large-scale variation in the human genome
Iafrate, A. J., Feuk, L., Rivera, M. N., Listewnik, M. L., Donahoe, P. K., Qi, Y., Scherer, S. W., & Lee, C. (2004) · Nature Genetics · doi:10.1038/ng1416 · Cited by 2,892
Schouten, J. P. (2002) · Nucleic Acids Research · doi:10.1093/nar/gnf056 · Cited by 2,699
Large-scale copy number polymorphism in the human genome
Sebat, J., Lakshmi, B., Troge, J., Alexander, J., Young, J., Lundin, P., Månér, S., Massa, H., Walker, M., Chi, M., et al. (2004) · Science · doi:10.1126/science.1098918 · Cited by 2,557
Structural variation in the human genome
Feuk, L., Carson, A. R., & Scherer, S. W. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1767 · Cited by 2,034
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Mullighan, C. G., Goorha, S., Radtke, I., Miller, C. B., Coustan-Smith, E., Dalton, J. D., Girtman, K., Mathew, S., Ma, J., Pounds, S. B., et al. (2007) · Nature · doi:10.1038/nature05690 · Cited by 1,801
Large recurrent microdeletions associated with schizophrenia.
GROUP, Stefansson, H., Rujescu, D., Cichon, S., Pietiläinen, O. P. H., Ingason, A., Steinberg, S., Fossdal, R., Sigurdsson, E., Sigmundsson, T., et al. (2008) · Nature · doi:10.1038/nature07229 · Cited by 1,745
Personal genomes: The case of the missing heritability
Maher, B. (2008) · Nature · doi:10.1038/456018a · Cited by 1,737
Cited by
Discovery and Statistical Genotyping of Copy-Number Variation from Whole-Exome Sequencing Depth
Fromer, M., Moran, J. L., Chambert, K., Banks, E., Bergen, S. E., Ruderfer, D. M., Handsaker, R. E., McCarroll, S. A., O’Donovan, M. C., Owen, M. J., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.08.005 · Cited by 563
“A number of studies have implicated deletion and duplication CNVs in cancer susceptibility, metastasis, gene expression, and treatment.(2) Similarly, rare CNVs are enriched in individuals with severe neuropsychiatric conditions, such as autism (MIM 209850), schizophrenia (MIM 181500), intellectual disability, and epil…”
BackgroundWhale, A. S., Huggett, J. F., Cowen, S., Speirs, V., Shaw, J., Ellison, S., Foy, C. A., & Scott, D. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks203 · Cited by 453
TSGene: a web resource for tumor suppressor genes
Zhao, M., Sun, J., & Zhao, Z. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks937 · Cited by 330
“In addition, TSGs have been widely reported to occur in the deletion regions of copy number aberration in the genome (6).”
BackgroundIonizing radiation biomarkers for potential use in epidemiological studies
Pernot, E., Hall, J., Baatout, S., Benotmane, M. A., Blanchardon, E., Bouffler, S., El Saghire, H., Gomolka, M., Guertler, A., Harms-Ringdahl, M., et al. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2012.05.003 · Cited by 213
“The role of CNVs in cancer has only emerged in the last few years when constitutional CNVs was observed in the Li-Fraumeni cancer susceptibility syndrome and in neuroblastoma [145].”
BackgroundUsing XHMM Software to Detect Copy Number Variation in Whole‐Exome Sequencing Data
Fromer, M., & Purcell, S. M. (2014) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg0723s81 · Cited by 178
“Numerous recent studies have implicated copy number variation (CNV) in many cancers (Pollack et al., 2002; Shlien and Malkin 2010) and severe neuropsychiatric conditions including autism (Pinto et al., 2010), schizophrenia (International Schizophrenia Consortium, 2008; Stefansson et al., 2008),…”
BackgroundSoni, S., Anand, P., & Padwad, Y. S. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1115-1 · Cited by 132
“Presently, several copy number variations (CNVs) have been shown to be associated with human diseases including cancers [41, 42].”
BackgroundThe discovery of human genetic variations and their use as disease markers: past, present and future
Ku, C., Loy, E. Y., Salim, A., Pawitan, Y., & Chia, K. S. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.55 · Cited by 137
Germline DNA copy number variation in familial and early-onset breast cancer
Krepischi, A. C. V., Achatz, M. I., Santos, É. M. M., da Costa, S. S., Lisbôa, B. C. G., Brentani, H., Santos, T. M., Gonçalves, A., de Nóbrega, A. F., Pearson, P. L., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3109 · Cited by 96
“Common CNVs often contain cancer-related genes and likely play a role in carcinogenesis [40].”
BackgroundJia, D., Jing, Y., Zhang, Z., Liu, L., Ding, J., Zhao, F., Ge, C., Wang, Q., Chen, T., Yao, M., et al. (2013) · Cell Research · doi:10.1038/cr.2013.158 · Cited by 86
Germline Copy Number Variations and Cancer Predisposition
Krepischi, A. C. V., Pearson, P. L., & Rosenberg, C. (2012) · Future Oncology · doi:10.2217/fon.12.34 · Cited by 82
Thomas, R. J., Borst, L. B., Rotroff, D. M., Motsinger‐Reif, A. A., Lindblad‐Toh, K., Modiano, J. F., & Breen, M. (2014) · Chromosome Research · doi:10.1007/s10577-014-9406-z · Cited by 79
“There is growing evidence for the involvement of these natural polymorphisms in a variety of human diseases, including cancer (for example, Fanciulli et al. 2010; Shlien and Malkin 2010).”
Horpaopan, S., Spier, I., Zink, A. M., Altmüller, J., Holzapfel, S., Laner, A., Vogt, S. L., Uhlhaas, S., Heilmann‐Heimbach, S., Stienen, D., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29215 · Cited by 67
“Germline copy number variants (CNVs) have been recognized as the most prevalent type of structural genetic variation, which also predispose to human disease as lowpenetrance risk factors or high-penetrance mutations.(1,2) Recent research has identified potentially causative germline deletions and duplications for a nu…”
BackgroundA Functional Copy-Number Variation in MAPKAPK2 Predicts Risk and Prognosis of Lung Cancer
Liu, B., Yang, L., Huang, B., Cheng, M., Wang, H., Li, Y., Huang, D., Zheng, J., Li, Q., Zhang, X., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.07.003 · Cited by 65
Overwater, E., Marsili, L., Baars, M. J. H., Baas, A. F., van de Beek, I., Dulfer, E., van Hagen, J. M., Hilhorst‐Hofstee, Y., Kempers, M. J. E., Krapels, I. P. C., et al. (2018) · Human Mutation · doi:10.1002/humu.23565 · Cited by 61
Analysis of Tumor Suppressor Genes Based on Gene Ontology and the KEGG Pathway
Yang, J., Chen, L., Kong, X., Huang, T., & Cai, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107202 · Cited by 60
“Increasing evidence has shown the abnormal DNA methylation or histone modifications, and non-coding RNA affect the expression of TSGs at the epigenetic level and post-transcriptional level, respectively [2,3].”
Bioinformatics for cancer immunology and immunotherapy
Charoentong, P., Angelova, M., Efremova, M., Gallasch, R., Hackl, H., Galon, J., & Trajanoski, Z. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1354-x · Cited by 54
“(b) Databases for copy number of variations (CNV) Results generated using various reliable platforms including NSG for high-resolution detection of DNA copy number changes are available [31, 34, 35].”
MethodUpadhyaya, M., Spurlock, G., Thomas, L. E., Thomas, N. S. T., Richards, M., Mautner, V.-F., Cooper, D. N., Guha, A., & Yan, J. S. (2012) · Human Mutation · doi:10.1002/humu.22044 · Cited by 56
“Although CNVs make a substantial contribution to interindividual variation, acquired somatic copy number alterations (CNAs) are increasingly being identified in many different cancers [Albertson, 2006; Kuiper et al., 2010; Rothenberg and Settleman, 2010; Shlien and Malkin, 2009, 2010].”
BackgroundCopy number expansion of the STX17 duplication in melanoma tissue from Grey horses
Sundström, E., Imsland, F., Mikko, S., Wade, C. M., Sigurðsson, S., Pielberg, G., Golovko, A., Čurik, I., Seltenhammer, M. H., Sölkner, J., et al. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-365 · Cited by 59
“The role of CNVs in cancer is an emerging field [13].”
Ultra-High Density SNParray in Neuroblastoma Molecular Diagnostics
Ambros, I. M., Brunner, C., Abbasi, R., Frech, C., & Ambros, P. F. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00202 · Cited by 47
“While most common CNVs have little or no role in causing diseases (28), some have been associated with susceptibility or resistance to diseases (29).”
BackgroundMu, W., Li, B., Wu, S., Chen, J., Sain, D., Xu, D. L., Black, M. H., Karam, R., Gillespie, K., Hagman, K. D. F., et al. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0397-6 · Cited by 50
Beal, M. A., Glenn, T. C., & Somers, C. M. (2011) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.11.002 · Cited by 41
Pichert, G., Mohammed, S. N., Ahn, J. W., Ogilvie, C. M., & Izatt, L. (2011) · Journal of Medical Genetics · doi:10.1136/jmg.2010.087593 · Cited by 37
“The advent of array CGH raises the possibility of findings in cancer predisposition genes in patients tested for entirely unconnected reasons such as developmental delay or birth defects.”
BackgroundSapkota, Y. (2014) · Cytogenetic and Genome Research · doi:10.1159/000369045 · Cited by 44
“…harboring CNVs and, therefore, GWASs utilizing CNVs are slowly emerging [Tuzun et al., 2005; McCarroll and Altshuler, Germline DNA Variants and Breast Cancer Cytogenet Genome Res 2014;144:77–91 DOI: 10.1159/000369045 85 2007; Wong et al., 2007; McCarroll et al., 2008; Shlien and Malkin, 2010].”
BackgroundInfluentialJin, D., Lee, J., Kim, K. M., Kim, S., Kim, D.-H., & Park, J. (2015) · Oncotarget · doi:10.18632/oncotarget.4171 · Cited by 36
“DNA copy number alteration (CNA) defined as DNA segments that are 1 kb or larger in size, is an important type of genetic alteration observed in cancer cells [2].”
Mining for novel tumor suppressor genes using a shortest path approach
Chen, L., Yang, J., Huang, T., Kong, X., Lu, L., & Cai, Y. (2015) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2015.1042915 · Cited by 29
“Moreover, it was reported that loss or haploinsuf fi ciency of TSGs coding proteins is attributable to aberrant DNA methylation or histone modi fi cations at the epigenetic level (Sherr, 2004; Shlien & Malkin, 2010).”
BackgroundZhao, K., Zhao, Y. Q., Zhu, J., Dong, H. F., Cong, W., Yu, Y., Wang, H., Zhu, Z., & Xu, Q. (2018) · Current Medical Science · doi:10.1007/s11596-018-1918-x · Cited by 24
Amplification and up-regulation of microRNA-30b in oral squamous cell cancers
Shao, C., Yu, Y.-L., Yu, L.-Y., Pei, Y., Feng, Q., Chu, F., Fang, Z., & Zhou, Y. (2012) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2012.04.002 · Cited by 25
Sapkota, Y., Ghosh, S., Lai, R. L., Coe, B. P., Cass, C. E., Yasui, Y., Mackey, J. R., & Damaraju, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053850 · Cited by 25
“Survival Analysis of CNAs and Statistical Considerations Of the CNAs identified by the SNP-FASST2 segmentation algorithm, we restricted our analysis to relatively high frequency common CNAs to evaluate their potential role in breast cancer recurrence because common CNVs often harbour cancer-related genes [37].”
MethodJin, D., Park, S., Lee, J., Kim, K., Kim, S., Kim, D.-H., & Park, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137657 · Cited by 22
“DNA copy number alteration (CNA) defined as DNA segments 1 kb or larger in size, is an important type of genetic alteration observed in cancer cells [5].”
BackgroundECOLE: Learning to call copy number variants on whole exome sequencing data
Mandiracioglu, B., Özden, F., Kaynar, G., Yılmaz, M. A., Alkan, C., & Çiçek, A. E. (2024) · Nature Communications · doi:10.1038/s41467-023-44116-y · Cited by 25
“Copy number variants (CNVs) are well-known and important risk factors for many conditions such as cancer [32,25], schizophrenia [33,1] and autism [14].”
Brusselaers, N., Ekwall, K., & Durand‐Dubief, M. (2019) · Human Genomics · doi:10.1186/s40246-019-0241-3 · Cited by 21
Highly Multiplexed Fluorescence in Situ Hybridization for in Situ Genomics
Onozato, M. L., Yapp, C., Richardson, D. S., Sundaresan, T. K., Chahal, V., Lee, J., Sullivan, J. P., Madden, M. W., Shim, H. S., Liebers, M. R., et al. (2019) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2019.01.010 · Cited by 21
Zhou, Y., Cheng, X., Zhang, F., Chen, Q., Chen, X., Shen, Y., Lai, C., Kota, V. G., Sun, W., Huang, Q., et al. (2020) · Human Mutation · doi:10.1002/humu.24059 · Cited by 22
“Apart from somatic point mutations (Loeb, Loeb, & Anderson, 2003), copynumber variations (CNV; Shlien & Malkin, 2010) and aberrant DNA methylation patterns (Baylin, 2005) also play critical roles in the development of cancer.”
BackgroundPedranzini, L., Mottadelli, F., Ronzoni, S., Rossella, F., Ferracin, M., Magnani, I., Roversi, G., Colapietro, P., Negrini, M., Pelicci, P. G., et al. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.02.012 · Cited by 21
de Clare, M., & Oliver, S. G. (2013) · BMC Biology · doi:10.1186/1741-7007-11-24 · Cited by 19
“© 2013 de Clare and Oliver; licensee BioMed C Creative Commons Attribution License (http:/ distribution, and reproduction in any medium cancer cells are coming to be seen as potentially causative, rather than simply symptomatic [2-4].”
BackgroundNOXIN as a cofactor of DNA polymerase-primase complex could promote hepatocellular carcinoma
Zhang, Z.-Z., Huang, J. J., Wang, Y., Cai, B., & Han, Z. (2015) · International Journal of Cancer · doi:10.1002/ijc.29451 · Cited by 18
“Oncogenes are known to be activated by DNA copy number amplification, point mutations and chromosomal translocations, whereas tumor suppressor genes can be inactivated by allelic deletion.(3,4) DNA copy number amplification was one of the most common genetic aberrant in humane HCC and therefore, based on DNA copy numb…”
BackgroundPark, C. H., Rha, S. Y., Ahn, J. B., Shin, S. J., Kwon, W. S., Kim, T. S., An, S., Kim, N. K., Yang, W., & Chung, H. C. (2014) · International Journal of Cancer · doi:10.1002/ijc.29273 · Cited by 17
“In this study, CNV was determined as a genetic alteration having a frequency higher than 20%.(5,18) The functions and biological roles of the selected CNVs were investigated using Core Analysis in Ingenuity Pathways Analysis (IPA) 5.”
MethodHu, W., Li, M., Zhang, Q., Liu, C., Wang, X., Li, J., Qiu, S., & Li, L. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00823-y · Cited by 15
“used gene chips to compare 770 normal genomes, and found that 49 oncogenes were surrounded by CNV [9].”
MethodGenomic Newborn Screening for Pediatric Cancer Predisposition Syndromes: A Holistic Approach
Linga, B. G., Mohammed, S. G. A. A., Farrell, T. J., Rifai, H. A., Al-Dewik, N. I. E., & Qoronfleh, M. W. (2024) · Cancers · doi:10.3390/cancers16112017 · Cited by 15
“Additionally, ~40% of the cancer genes identified in the “Census of Human Cancer Genes” were influenced by CNVs [62,64].”
BackgroundMa, J., Shao, L., Fuksenko, T., Liu, H., Shi, R., Dinh, A., Highfill, S. L., Zhang, N., Panch, S. R., Somerville, R. P. T., et al. (2023) · Cytotherapy · doi:10.1016/j.jcyt.2023.02.010 · Cited by 14
Liao, W., Wan, L., Wang, T.-Y., Chen, C., Tse, S.-S., Lu, C.-H., & Tsai, F. (2014) · BMC Ophthalmology · doi:10.1186/1471-2415-14-15 · Cited by 14
“For example, the associations between CNV and diseases such as autism [3,4], schizophrenia [5], cancer [6-8], and autoimmune disorders [9-13] have been discussed in numerous studies.”
BackgroundFast Bayesian Inference of Copy Number Variants using Hidden Markov Models with Wavelet Compression
Wiedenhoeft, J., Brugel, E., & Schliep, A. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004871 · Cited by 12
“Separating common from rare variants is important in the study of genetic diseases [5, 11, 12], and while the experimental platforms have matured, interpretation and assessment of pathogenic significance remains a challenge [13].”
BackgroundYang, B., Zhou, M., Wu, Y., Ma, Y., Tan, Q., Yuan, W., & Ma, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.769047 · Cited by 10
Masson, A. L., Talseth‐Palmer, B. A., Evans, T., McElduff, P., Spigelman, A. D., Hannan, G. N., & Scott, R. J. (2015) · Meta Gene · doi:10.1016/j.mgene.2015.12.005 · Cited by 11
“Furthermore, while CNVs which are commonly observed in the population may contain cancer related genes, it is the rare CNVs (low population frequencies) which are proposed to harbour genes or other regulatory elements that are likely to be disease susceptibility factors(Shlien and Malkin, 2010).”
BackgroundHopman, S. M. J., Merks, J. H. M., Eussen, H. J., Douben, H., Snijder, S., Hennekam, R. C. M., de Klein, A., & Caron, H. N. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.02.002 · Cited by 9
Li, J., Ye, T., Wang, Z., Liu, Y., Xiao-bo, D., & Zhu, Y. (2021) · Journal of Oncology · doi:10.1155/2021/7404927 · Cited by 8
“CNV was one of the primary forms of cancer genetic alteration, and CNV patterns in different cancer types varied [37].”
BackgroundLarge Germline Copy Number Variations as Predisposing Factor in Childhood Neoplasms
Krepischi, A. C. V., Capelli, L. P., Silva, A. G., de Araújo, É. S. S., Pearson, P. L., Heck, B., da Costa, C. M. L., de Camargo, B., & Rosenberg, C. (2014) · Future Oncology · doi:10.2217/fon.14.41 · Cited by 8
reconCNV: interactive visualization of copy number data from high-throughput sequencing
Chandramohan, R., Kakkar, N., Roy, A., & Parsons, D. W. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa746 · Cited by 8
Zhou, Z.-T., Wu, J.-J., Ma, W., Dong, F., & Wang, J.-F. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17634 · Cited by 6
Bødker, J. S., Gyrup, C., Johansen, P., Schmitz, A., Madsen, J. G., Johnsen, H. E., Bøgsted, M., Dybkær, K., & Nyegaard, M. (2012) · Cytogenetic and Genome Research · doi:10.1159/000345125 · Cited by 7
“…diseases from mental retardation to various cancer forms are being revealed using commercial microarrays supplied from a range of different companies utilizing various technological platforms [Rodriguez-Revenga et al., 2007; Curtis et al., 2009; Shlien and Malkin, 2010; Hochstenbach et al., 2011].”
BackgroundSequencing XMET genes to promote genotype-guided risk assessment and precision medicine
Jin, Y., Chen, G., Xiao, W., Hong, H., Xu, J., Guo, Y., Xiao, W., Shi, T., Shi, L. M., Tong, W., et al. (2019) · Science China Life Sciences · doi:10.1007/s11427-018-9479-5 · Cited by 5
Interpretable CNV-based tumour classification using fuzzy rule based classifiers
Ricatto, M., Barsacchi, M., & Bechini, A. (2018) · ACM Symposium on Applied Computing · doi:10.1145/3167132.3167135 · Cited by 6
“The relationship between copy number variations and cancer has been recently investigated [23, 24], and it has been suggested that CNVs could play a non-trivial role in cancer evolution.”
BackgroundThe PLCE1 rs2274223 variant is associated with the risk of laryngeal squamous cell carcinoma
Zhang, Y., Li, W., Wang, Y., & Wang, N. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.49012 · Cited by 5
“Investigation of tumor susceptibility is of particular significance for cancer evaluation and therapy [29], and many SNPs had been extensively confirmed to be associated with tumor susceptibility [30-34].”
BackgroundCurcumin: Towards molecularly targeted chemoprevention of cancer
Pfeffer, U., Amaro, A. A., Bachmeier, B. E., & Angelini, G. (2014) · European Journal of Molecular & Clinical Medicine · doi:10.1016/j.nhtm.2014.08.005 · Cited by 3
“So far, most studies have considered only single nucleotide polymorphisms (SNPs) but more recently, the presence of deletions, insertions, amplifications, and inversions involving hundreds of basepairs has shown to be frequent in the general population and most likely contribute to the cancer risk [6,7].”
BackgroundMascelli, S., Severino, M., Raso, A., Nozza, P., Tassano, E., Morana, G., Marco, P. D., Merello, E., Milanaccio, C., Pavanello, M., et al. (2014) · Molecular Cytogenetics · doi:10.1186/1755-8166-7-31 · Cited by 3
“While the significance of CNVs to human pathology is being recognized, it is unclear how common or functionally relevant CNVs are to the process of carcinogenesis [10].”
BackgroundAssociation of TSHR Gene Copy Number Variation with TSH Abnormalities
Pang, Y., Guan, Y., Jin, X. Y., Shen, H., Liu, L., Jia, Q., Meng, F., & Zhang, X. (2018) · Biological Trace Element Research · doi:10.1007/s12011-018-1300-7 · Cited by 3
Lage, L. B., Freitas‐Júnior, R., Corrêa, R. D. S., dos Santos, E. E., Ferreira, N. C., Silva, N. C., & Soares, L. R. (2020) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2020.0041.r1.04052020 · Cited by 3
Fromer, M., & Purcell, S. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2824-8_4 · Cited by 2
Screening for common copy-number variants in cancer genes
Tyson, J., Majerus, T. M. O., Walker, S., & Armour, J. A. L. (2010) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2010.08.008 · Cited by 4
“Studies on inherited cancer syndromes have provided evidence for a role of CNVs in cancer predisposition (reviewed in [35,36]).”
BackgroundGermline Genomic Copy Number Variation Contribution to Cancer Predisposition
Silva, A. G., Rodrigues, T. C., Pearson, P. L., Rosenberg, C., & Krepischi, A. C. V. (2013) · Wiley eBooks · doi:10.1002/9780470015902.a0025028 · Cited by 2
“In fact, a study on DGV data claimed that nearly 40%of known cancer-related genes are affected by a CNV in normal individuals (Shlien and Malkin, 2010).”
BackgroundRole of Polymorphisms in Cancer Susceptibility
Tan, I. B., Ngeow, J. Y. Y., & Tan, P. B. O. (2010) · Wiley eBooks · doi:10.1002/9780470015902.a0022403 · Cited by 5
Germline Copy Number Variation and Cancer Risk
de Voer, R. M., Venkatachalam, R., van Kessel, A. G., & Kuiper, R. P. (2012) · Wiley eBooks · doi:10.1002/9780470015902.a0023854 · Cited by 2
A Novel Graph-based Algorithm to Infer Recurrent Copy Number Variations in Cancer
Chi, C., Ajwad, R., Kuang, Q., & Hu, P. (2016) · Cancer Informatics · doi:10.4137/cin.s39368 · Cited by 2
“A 9–12 In one study, CNV detected in 1,400 regions have overlaps with 14.5% of human disease-causal genes.”
BackgroundInfluentialShen, M., Huang, C., Ho, T.-F., Liu, C., Shih, Y.-Y., Huang, C.-S., & Huang, C. (2022) · BMC Cancer · doi:10.1186/s12885-022-09627-9 · Cited by 1
“Chromosomal aberrations seem to play a major role in regulating transcription [31, 32].”
BackgroundLee, D. (2024) · Korean Journal of Clinical Laboratory Science · doi:10.15324/kjcls.2024.56.4.307 · Cited by 1
Lu, T., Lai, L., Chuhsing, K. H., Chen, P., Tsai, M., & Eric, Y. C. (2010) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2010.5706578 · Cited by 1
Genome‐wide Association Studies of Cancers
Ku, C., Naidoo, N., Hartman, M., & Pawitan, Y. (2010) · Wiley eBooks · doi:10.1002/9780470015902.a0022659 · Cited by 1
Cancer predisposition in children: genetics, phenotypes & screening
Hopman, S. M. J. (2014) · Data Archiving and Networked Services (DANS)
Structural variants in the great tit genome and their effect on seasonal timing
da Silva, V. H. (2020) · doi:10.18174/512907 · Cited by 3
Post-zygotic Genetic Variation in Health and Disease
Razzaghian, H. R. (2013) · Uppsala University Publications (Uppsala University)
Copy number variations and cancer susceptibility: Retraction
(2016) · Current Opinion in Oncology · doi:10.1097/01.cco.0000491182.00738.ba
“Due to author oversight, the article, ‘Copy number variations and cancer susceptibility’ by David Malkin and Adam Shlien [1] was published in a similar form in the journal, Genome Medicine [2].”
BackgroundRetractedBeal, M. A. (2017) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2017-11975
Hu, W., Li, M., Zhang, Q., Liu, C., Wang, X., Li, J., Qiu, S., & Li, L. (2021) · Figshare · doi:10.6084/m9.figshare.15130963
Shen, M.-H., Huang, C.-J., Ho, T.-F., Liu, C.-Y., Shih, Y.-Y., Huang, C.-S., & Huang, C.-C. (2022) · Figshare · doi:10.6084/m9.figshare.19933050
Shen, M.-H., Huang, C.-J., Ho, T.-F., Liu, C.-Y., Shih, Y.-Y., Huang, C.-S., & Huang, C.-C. (2022) · Figshare · doi:10.6084/m9.figshare.19933053
Upadhyaya, M., & Cooper, D. N. (2012) · Springer eBooks · doi:10.1007/978-3-642-32864-0_27
Metadata
- Authors
- Shlien, A., & Malkin, D.
- Affiliations
- Hospital for Sick Children (CA)
- Corresponding author
- Malkin, David
- Venue
- Current Opinion in Oncology
- Published
- 2010-01
- Volume
- 22
- Issue
- 1
- Pages
- 55-63
- ISSN
- 1040-8746 (ISSN-L)
- OpenAlex
- W2013249386
- Cited by
- 77
- References
- 77
- Citations by year
- 2024: 3 · 2023: 1 · 2022: 4 · 2021: 4 · 2020: 5 · 2019: 4 · 2018: 5 · 2017: 1 · 2016: 3 · 2015: 6 · 2014: 12 · 2013: 6 · 2012: 15
- FWCI
- 4.46
- Type
- journal article
- Language
- en
- Status
- Retracted
- Update notices
- retraction (2016-09-01)
- Open access
- closed
- Locations
- Current Opinion in Oncology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genome Rearrangement Algorithms
- Keywords
- copy number variation, cancer susceptibility, somatic copy number variation, Li-Fraumeni syndrome, neuroblastoma, carcinogenesis, SNP array
- MeSH terms
- Humans, Neoplasms, Gene Dosage, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.